Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Therapies Année : 2020

Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus

Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus

Résumé

Recently, the International Association of Therapeutic Drug Monitoring (IATDMCT), that is the learning society for biological pharmacology and toxicology, issued recommendations on the therapeutic drug monitoring (TDM) of tacrolimus. This is the second consensus after the one issued in 2009. In this document, the role of tacrolimus TDM for the four principal transplanted organs is discussed. The analytical aspects, pharmacogenetics, TDM alternative approaches and the positioning of biomarkers are also presented. Stronger recommendations are about trough concentration targets in kidney and liver transplantation and for other indication of tacrolimus use. For the first time, an area under the curve of tacrolimus concentrations target is recommended for recipients management. Eventually, another set of recommendations are proposed for pharmacodynamic biomarkers used in patients’ follow-up.
Fichier principal
Vignette du fichier
Lemaitre et al-2020-Synthèse des recommandations de l’International Association of Therapeutic Drug.pdf (327.47 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02934300 , version 1 (10-09-2020)

Identifiants

Citer

F. Lemaître, C. Monchaud, J.-B. Woillard, N. Picard, Philippe Marquet. Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus. Therapies, 2020, 75 (6), pp.681-685. ⟨10.1016/j.therap.2020.06.004⟩. ⟨hal-02934300⟩
447 Consultations
349 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More